Colozza, M <br/><br/>
Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.  [electronic resource] 

 -  American journal of clinical oncology  Oct 1997 
 - 522-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0277-3732 
<br/><br/><label>Standard No.: </label>10.1097/00000421-199710000-00019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Ascites--pathology<br/>Carcinoma--drug therapy<br/>Cisplatin--administration & dosage<br/>Confidence Intervals<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Forecasting<br/>Humans<br/>Laparotomy<br/>Longitudinal Studies<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Staging<br/>Neoplasm, Residual<br/>Ovarian Neoplasms--drug therapy<br/>Prognosis<br/>Remission Induction<br/>Reoperation<br/>Survival Rate